PubMed:26596400 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PubMed/sourceid/26596400","sourcedb":"PubMed","sourceid":"26596400","source_url":"http://www.ncbi.nlm.nih.gov/pubmed/26596400","text":"Postoperative Complications in the Ahmed Baerveldt Comparison Study During Five Years of Follow-up.\nPURPOSE: To compare the late complications in the Ahmed Baerveldt Comparison Study during 5 years of follow-up.\nDESIGN: Multicenter, prospective randomized clinical trial.\nMETHODS: setting: Sixteen international clinical centers.\nSTUDY POPULATION: Two hundred seventy-six subjects aged 18-85 years with previous intraocular surgery or refractory glaucoma with intraocular pressure of \u003e18 mm Hg.\nINTERVENTIONS: Ahmed Glaucoma Valve FP7 or Baerveldt Glaucoma Implant BG 101-350.\nMAIN OUTCOME MEASURES: Late postoperative complications (beyond 3 months), reoperations for complications, and decreased vision from complications.\nRESULTS: Late complications developed in 56 subjects (46.8 ± 4.8 5-year cumulative % ± SE) in the Ahmed Glaucoma Valve group and 67 (56.3 ± 4.7 5-year cumulative % ± SE) in the Baerveldt Glaucoma Implant group (P = .082). The cumulative rates of serious complications were 15.9% and 24.7% in the Ahmed Glaucoma Valve and Baerveldt Glaucoma Implant groups, respectively (P = .034), although this was largely driven by subjects who had tube occlusions in the 2 groups (0.8% in the Ahmed Glaucoma Valve group and 5.7% in the Baerveldt Glaucoma Implant group, P = .037). Both groups had a relatively high incidence of persistent diplopia (12%) and corneal edema (20%), although half of the corneal edema cases were likely due to pre-existing causes other than the aqueous shunt. The incidence of tube erosion was 1% and 3% in the Ahmed Glaucoma Valve and Baerveldt Glaucoma Implant groups, respectively (P = .04).\nCONCLUSIONS: Long-term rates of vision-threatening complications and complications resulting in reoperation were higher in the Baerveldt Glaucoma Implant than in the Ahmed Glaucoma Valve group over 5 years of follow-up.","tracks":[{"project":"maxiaofeng52_800","denotations":[{"id":"T1","span":{"begin":516,"end":524},"obj":"DP"},{"id":"T2","span":{"begin":446,"end":454},"obj":"DP"},{"id":"T3","span":{"begin":548,"end":556},"obj":"DP"},{"id":"T4","span":{"begin":829,"end":837},"obj":"DP"},{"id":"T5","span":{"begin":912,"end":920},"obj":"DP"},{"id":"T6","span":{"begin":1056,"end":1064},"obj":"DP"},{"id":"T7","span":{"begin":1027,"end":1035},"obj":"DP"},{"id":"T8","span":{"begin":1210,"end":1218},"obj":"DP"},{"id":"T9","span":{"begin":1257,"end":1265},"obj":"DP"},{"id":"T10","span":{"begin":1557,"end":1565},"obj":"DP"},{"id":"T11","span":{"begin":1586,"end":1594},"obj":"DP"},{"id":"T12","span":{"begin":1772,"end":1780},"obj":"DP"},{"id":"T13","span":{"begin":1807,"end":1815},"obj":"DP"}],"attributes":[{"subj":"T1","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T2","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T3","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T4","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T5","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T6","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T7","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T8","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T9","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T10","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T11","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T12","pred":"source","obj":"maxiaofeng52_800"},{"subj":"T13","pred":"source","obj":"maxiaofeng52_800"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"maxiaofeng52_800","color":"#93a9ec","default":true}]}]}}